Medical News

RSS

Certain forms of abuse negatively influence women cancer patients' quality of life

A new study by University of Kentucky researchers shows evidence that certain forms of abuse negatively influence women cancer patients' quality of life.

28 Jan 2013

Study sheds new light on why certain people are more likely to suffer from RA

University of Michigan research sheds new light on why certain people are more likely to suffer from rheumatoid arthritis - paving the way to explore new treatments for both arthritis and other autoimmune diseases.

28 Jan 2013

AstraZeneca, Orexo partner on OX-CLI preclinical program to treat respiratory diseases

Orexo AB announced today that the company has entered into an agreement with AstraZeneca regarding OX-CLI, a preclinical program for a potential novel treatment of respiratory diseases.

28 Jan 2013

Transcat acquires Cal-Matrix

Transcat, Inc., a leading distributor of professional grade handheld test, measurement and control instruments and accredited provider of calibration, repair, inspection and other compliance services, announced today that it has acquired Cal-Matrix Metrology Inc., a leading Canadian provider of commercial and accredited calibrations and coordinate measurement inspection services.

28 Jan 2013

TSRI scientists to identify, test and develop drug candidates for several neurodegenerative disorders

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded approximately $1.2 million from the U.S. National Institute of General Medical Sciences of the National Institutes of Health to identify, test and develop a series of drug candidates for a number of diseases, including rheumatoid arthritis, heart disease and several neurodegenerative disorders.

28 Jan 2013

Lincor Solutions to showcase latest developments in MEDIVista at Arab Health 2013

As part of the Ireland Pavilion at Arab Health 2013, Lincor Solutions, the global leaders in point of care computing, will be showcasing the latest developments in MEDIVista. These include significant enhancements to the MEDIVista enterprise server, new hardware and a preview of future developments.

28 Jan 2013

Gilead commences first of two tenofovir alafenamide Phase 3 trials in HIV

Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.

28 Jan 2013

IRHOM2-targeted drugs can effectively treat patients with rheumatoid arthritis

Researchers at Hospital for Special Surgery have identified a potential new target for drugs to treat patients with rheumatoid arthritis (RA), a protein known as IRHOM2. The finding could provide an effective and potentially less toxic alternative therapy to tumor necrosis factor-alpha blockers (TNF-blockers), the mainstay of treatment for rheumatoid arthritis, and could help patients who do not respond to this treatment. Efforts to develop drugs that hone in on this new target are underway.

28 Jan 2013

Research reveals the mechanism of epigenetic reprogramming

New research reveals a potential way for how parents' experiences could be passed to their offspring's genes.

28 Jan 2013

Less invasive treatment can provide superior survival to mastectomy in early stage breast cancer

Patients with early stage breast cancer who are treated with lumpectomy plus radiation have a better chance of survival compared with those who undergo mastectomy, according to Duke Medicine research.

28 Jan 2013

New AngioSculpt catheters from AngioScore can treat peripheral artery disease below the knee

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, today announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK).

28 Jan 2013

First Edition: January 25, 2013

Today's headlines include various state-level reports about how budget issues are impacting health policy decisions.

28 Jan 2013

FDA approves Pfizer’s Prevnar 13 to prevent pneumococcal disease in older children, adolescents

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the expansion of the company's pneumococcal conjugate vaccine, Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for use in older children and adolescents aged 6 years through 17 years for active immunization for the prevention of invasive disease caused by the 13 Streptococcus pneumoniae serotypes contained in the vaccine.

28 Jan 2013

Qigong reduces depressive symptoms and improves QOL in women with breast cancer

Researchers from The University of Texas MD Anderson Cancer Center have found qigong, an ancient mind-body practice, reduces depressive symptoms and improves quality of life in women undergoing radiotherapy for breast cancer.

28 Jan 2013

Toshiba enters agreement to acquire majority shares of TMST

Toshiba Medical Systems Corporation, a group company of Toshiba Corporation, today announced that it has entered into an agreement to acquire a majority shares of the stock of a distributor in Turkey, TMST Tıbbi Sistemler Pazarlama Ticaret ve Servis A.S. handling medical diagnostic imaging systems sales and services of TMSC products in Turkish market.

28 Jan 2013

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.

28 Jan 2013

Results from Amgen’s Neulasta plus bevacizumab Phase 3 trial on colorectal cancer

Amgen announced today results from Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES), a Phase 3 trial which evaluated Neulasta (pegfilgrastim) in 845 patients receiving FOLFOX or FOLFIRI and bevacizumab for the first-line treatment of locally-advanced or metastatic colorectal cancer.

28 Jan 2013

Leading-edge Masimo medical devices to be displayed at Arab Health

Masimo returns to Arab Health Jan. 28-31, the world's longest running healthcare exhibition and congress held each year in Dubai, UAE, to showcase advanced, noninvasive patient monitoring technologies – including breakthrough SET Measure-Through Motion pulse oximetry and rainbow Pulse CO-Oximetry – that are becoming the standard-of-care across the Middle East.

28 Jan 2013

Telomerase gene mutation immortalizes deadly skin cancer

About ten percent of all cases of malignant melanoma are familial cases. The genome of affected families tells scientists a lot about how the disease develops. Prof. Dr. Rajiv Kumar of the German Cancer Research Center together with Prof. Dr. Dirk Schadendorf from Essen University Hospital studied a family where 14 family members were affected by malignant melanoma.

28 Jan 2013

Study shows how GATA3 protein acts downstream biochemically to prevent breast cancer metastasis

The spread of breast cancer to distant organs within the body, an event that often leads to death, appears in many cases to involve the loss of a key protein, according to UC San Francisco researchers, whose new discoveries point to possible targets for therapy.

28 Jan 2013

Medical News

Certain forms of abuse negatively influence women cancer patients' quality of life

Study sheds new light on why certain people are more likely to suffer from RA

AstraZeneca, Orexo partner on OX-CLI preclinical program to treat respiratory diseases

Transcat acquires Cal-Matrix

TSRI scientists to identify, test and develop drug candidates for several neurodegenerative disorders

Lincor Solutions to showcase latest developments in MEDIVista at Arab Health 2013

Gilead commences first of two tenofovir alafenamide Phase 3 trials in HIV

IRHOM2-targeted drugs can effectively treat patients with rheumatoid arthritis

Research reveals the mechanism of epigenetic reprogramming

Less invasive treatment can provide superior survival to mastectomy in early stage breast cancer

New AngioSculpt catheters from AngioScore can treat peripheral artery disease below the knee

First Edition: January 25, 2013

FDA approves Pfizer’s Prevnar 13 to prevent pneumococcal disease in older children, adolescents

Qigong reduces depressive symptoms and improves QOL in women with breast cancer

Toshiba enters agreement to acquire majority shares of TMST

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Results from Amgen’s Neulasta plus bevacizumab Phase 3 trial on colorectal cancer

Leading-edge Masimo medical devices to be displayed at Arab Health

Telomerase gene mutation immortalizes deadly skin cancer

Study shows how GATA3 protein acts downstream biochemically to prevent breast cancer metastasis

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News